R. Woods
Director/Board Member at X4 PHARMACEUTICALS, INC.
Net worth: 1 M $ as of 2024-03-30
Profile
Currently, R. Keith Woods holds the position of Chief Operating Officer of argenx SE. In his past career he held the position of SVP-North American Operations at Alexion Pharmaceuticals, Inc. and Vice president & Managing Director at Alexion Pharma UK Ltd. (a subsidiary of Alexion Pharmaceuticals, Inc.). He received an undergraduate degree from Florida State University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ARGEN-X SE
0.01% | 2024-02-19 | 3,307 ( 0.01% ) | 1 M $ | 2024-03-30 |
X4 PHARMACEUTICALS, INC.
0.05% | 2023-10-15 | 90,000 ( 0.05% ) | 125 100 $ | 2024-03-30 |
R. Woods active positions
| Companies | Position | Start |
|---|---|---|
| X4 PHARMACEUTICALS, INC. | Director/Board Member | 2023-10-15 |
| TSCAN THERAPEUTICS, INC. | Director/Board Member | 2023-12-05 |
| ROCKET PHARMACEUTICALS, INC. | Director/Board Member | 2023-12-11 |
Former positions of R. Woods
| Companies | Position | End |
|---|---|---|
| ARGENX SE | Chief Operating Officer | 2023-03-12 |
Alexion Pharma UK Ltd.
 Alexion Pharma UK Ltd. Medical DistributorsDistribution Services Part of AstraZeneca PLC, Alexion Pharma UK Ltd. is a pharmaceutical wholesaler founded in 2006. The private company is based in Middlesex, UK. | Corporate Officer/Principal | - |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Training of R. Woods
| Florida State University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| ARGENX SE | Health Technology |
| ROCKET PHARMACEUTICALS, INC. | Health Technology |
| TSCAN THERAPEUTICS, INC. | Health Technology |
| X4 PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Alexion Pharma UK Ltd.
Alexion Pharma UK Ltd. Medical DistributorsDistribution Services Part of AstraZeneca PLC, Alexion Pharma UK Ltd. is a pharmaceutical wholesaler founded in 2006. The private company is based in Middlesex, UK. | Distribution Services |
- Stock Market
- Insiders
- R. Woods
